Monoclonal Ribosomal P Autoantibody Inhibits the Expression and Release of Il-12, Tnf-α and Inos in Activated Raw Macrophage Cell Line
Resource
JOURNAL OF AUTOIMMUNITY v.24 n.2 pp.135-143
Journal
JOURNAL OF AUTOIMMUNITY
Journal Volume
v.24
Journal Issue
n.2
Pages
135-143
Date Issued
2005
Date
2005
Author(s)
Sun, Kuang-Hui
Tang, Shye-Jye
Chen, Chau-Yaun
Lee, Tai-Ping
Feng, Chi-Kuang
Yu, Chia-Li
Abstract
Monoclonal ribosomal P protein antibody (anti-P mAb) may bind to the cell surface, penetrate into cells, and induce apoptosis of Jurkat T cells. Recently, modulation of cytokines has been considered to be important in the pathogenesis of systemic lupus erythematous (SLE). In this study, effects of anti-P mAbs (9B6) on gene expression of cytokines, apoptosis, and reactive oxygen species in murine macrophage RAW 264.7 were analyzed by RT–PCR and ELISA and those on IL-12 promoter activity was determined in an IL-12p 40 promoter-reporter gene transfected cell line RAW (IL-12p 40-SEAP). After treating LPS-activated RAW 264.7 with 9B6 for 6 or 24 h, the levels of mRNA and protein expression of IL-12, TNF-α, and iNOS were significantly inhibited by 25%, 16%, and 13%, respectively. The IL-12 promoter activity of RAW (IL-12p40-SEAP) was also inhibited by 13–22%. However, inhibitory effects were not observed in cells pre-treated with IgG1 for 1 h. The productions of IL-10 in LPS-activated RAW 264.7 and human macrophages were potentiated by 9B6 up to 65% and 51%, respectively. Since anti-P Abs inhibit productions of IL-12 and TNF-α and enhance IL- 10 production in macrophages, these autoantibodies may augment Th2 responses and amplify lupus manifestations by causing immunological polarity and lymphocyte dysfunction.
Subjects
Anti-P autoantibody
Interleukin-12
Macrophage
Systemic lupus erythematosus
tumor necrosis factor α
interleukin-10